196 related articles for article (PubMed ID: 10450451)
1. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial.
Lang J; Hoa DQ; Gioi NV; Vien NC; Nguyen CV; Rouyrre N; Forrat R
Trans R Soc Trop Med Hyg; 1999; 93(2):208-13. PubMed ID: 10450451
[TBL] [Abstract][Full Text] [Related]
2. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
Lang J; Feroldi E; Vien NC
J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.
Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR
Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817
[TBL] [Abstract][Full Text] [Related]
5. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
[TBL] [Abstract][Full Text] [Related]
6. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
7. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine.
Sabchareon A; Chantavanich P; Pasuralertsakul S; Pojjaroen-Anant C; Prarinyanupharb V; Attanath P; Singhasivanon V; Buppodom W; Lang J
Pediatr Infect Dis J; 1998 Nov; 17(11):1001-7. PubMed ID: 9849982
[TBL] [Abstract][Full Text] [Related]
8. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
Vien NC; Feroldi E; Lang J
Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine.
Phanuphak P; Khawplod P; Sirivichayakul S; Siriprasomsub W; Ubol S; Thaweepathomwat M
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):33-7. PubMed ID: 3620048
[TBL] [Abstract][Full Text] [Related]
11. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
Arora A; Moeller L; Froeschle J
J Travel Med; 2004; 11(4):195-9. PubMed ID: 15541220
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
Pineda-Peña AC; Jiang Q; Petit C; Korejwo-Peyramond J; Donazzolo Y; Latreille M; Homery MC; Babin V; Benamor S; Pichon S; Guinet-Morlot F; Minutello AM
Clin Infect Dis; 2024 Jun; 78(6):1748-1756. PubMed ID: 38478634
[TBL] [Abstract][Full Text] [Related]
14. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
[TBL] [Abstract][Full Text] [Related]
15. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
16. A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
Pichon S; Guinet-Morlot F; Minutello M; Donazzolo Y; Rouzier R; Chassard D; Fitoussi S; Hou V
Vaccine; 2013 Apr; 31(18):2295-301. PubMed ID: 23510665
[TBL] [Abstract][Full Text] [Related]
17. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G
Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
Quiambao BP; Lang J; Vital S; Montalban CG; Le Mener V; Wood SC; Miranda E
Acta Trop; 2000 Feb; 75(1):39-52. PubMed ID: 10708006
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
Deshpande AK; Londhe VA; Akarte S; Briggs D
J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
